Exacerbation-prone asthma subtype has been reported in studies using data-driven methodologies. However, patterns of severe exacerbations have not been studied.
| INTRODUC TI ON
Asthma is the most common chronic disease in children. Despite advances in treatment and changes in guidelines, severe exacerbations continue to occur, thus creating a major burden on not only the child and the child's family, but also on healthcare resources. 1 Notably, a small proportion of children with frequent severe exacerbations account for the majority of the total disease burden in childhood. 2 Recent studies utilizing data-driven methods have shown that exacerbations may provide meaningful insight into understanding asthma heterogeneity. 3, 4 Identified risk factors for severe exacerbations include younger age, male sex, race, parental smoking history, socio-economic status, diminished lung function, severe exacerbation in previous year, respiratory virus infections, and synergistic effects of allergen sensitization, exposure and virus infection. [5] [6] [7] [8] [9] [10] [11] However, despite the current advancement of knowledge and treatment options in this domain, preventing an impending exacerbation remains difficult. 12 A recent randomized controlled trial in school-age children has shown that quintupling the dose of inhaled corticosteroids (ICS) at the early signs of loss of asthma control did not prevent a full-blown exacerbation. 13 Exacerbations encompass the crux of the definition of severe asthma, in that asthma is considered to be severe if a patient had frequent severe (use of oral steroids) or serious (hospital admission) exacerbations along with poor symptom control and airflow limitation. 14, 15 However, children can have asthma attacks despite good adherence with treatment and relatively good symptom control.
Studies using data-driven methods have shown that exacerbations are present within different asthma clusters of varying disease severity, 3, 4 and that patients with mild disease can have high rates of severe exacerbations, whereby decreasing symptoms may not always mean a decrease in the number of exacerbations. 7, 16 Using data-driven techniques, we have recently identified an exacerbation-prone asthma cluster that contained a proportion of children with mild asthma and normal lung function. 3 This data suggests that patients with exacerbations may account for a separate susceptibility phenotype, relatively independent of whether or not a child is deemed to have severe asthma, with a likely unique aetiology.
We hypothesized that there are distinct patterns of severe exacerbations of wheezing/asthma during childhood, and that uncovering such patterns may help ascertain whether they are underpinned by different mechanisms. To address our hypothesis, within an unselected birth cohort, we identified longitudinal trajectories of severe exacerbations of wheezing by analysing exacerbation patterns from birth to school age. We then examined their early-life risk factors, and asthma-related outcomes and lung function measures in late childhood.
| ME THODS

| Study population
The Manchester Asthma and Allergy Study is a population-based birth cohort and is described in detail elsewhere. 17 Subjects were recruited prenatally and followed prospectively. The study was approved by the Local Ethics Committee. Parents provided written informed consent. For more details about methods and variable definitions please see Online supplement.
| Data sources and definition of variables to identify exacerbation trajectories
We extracted data from electronic and paper-based primary care medical records, including prescriptions of any medication (type, dose and indication) including oral corticosteroid, episodes of wheeze, emergency department admissions, and asthma or wheeze-related admissions to hospital. Age in days at the time of each event was documented. 18 These data were available from birth to age 8 years.
| Severe exacerbation of wheeze/asthma
Defined from medical records as either receipt of oral corticosteroids (OCS) for at least 3 days, or emergency department visit because of asthma/wheeze requiring systemic corticosteroids or hospital admission. 19 We ascertained age in days of each exacerbation to provide an accurate account of each episode. 
| Data sources and definition of variables to validate exacerbation trajectories
Conclusion:
We have identified two distinct trajectories of severe exacerbations during childhood with different early-life risk factors and asthma-related outcomes in adolescence.
K E Y W O R D S
asthma exacerbations, childhood asthma, machine learning, primary care data collect information on symptoms, environmental exposure and treatments received. Early-life risk factors, including environmental tobacco smoke (ETS) exposure, pet ownership, length of breastfeeding, day-care attendance, presence of older siblings and family history of asthma, were ascertained during the last trimester of pregnancy and in the first year of life. Allergic sensitization was determined using skin prick tests (SPT) to common inhalant and food allergens.
| Current asthma at age 16 years
Defined as the presence of any two of the following three features: 1) Current wheeze; 2) Current use of asthma medication; and 3)
Physician-diagnosed asthma ever. 20
| Asthma severity
We created a composite variable to represent symptom control and step in medication based on the British Thoracic Society (BTS) guidelines. 21 Children on BTS step 1 and 2 were considered to have 'Mild asthma', and those on steps 3 and above 'Moderately severe asthma'.
Missing data were considered to be missing at random.
| Lung function, airway hyperreactivity and airway inflammation
We measured lung function using spirometry at ages 8, 11 and 16 years using a Lilly pneumotachograph with animated incentive software (Jaeger, Würzburg, Germany), or for home visits, a flow turbine spirometer (Micro Medical, UK). 22 FEV 1 % predicted 23 and FEV 1 /FVC ratio were recorded.
Specific airway resistance (sR aw ) was measured using plethysmography (Masterscreen Body 4.34; Jaeger) at ages 3, 5, 8, 11 and 16.
Airway hyperreactivity (AHR) was measured using standard protocol with quadrupling doses of methacholine in a 5-stage process at age 8. 24 We calculated dose-response slope 25 as indicator of AHR.
We measured Fractional Exhaled nitric oxide (FeNO) as a biomarker of airway inflammation at ages 8 and 16 years according to the American Thoracic Society guidelines using either a chemiluminescence analyser or an electrochemical analyser (NIOX, Solna, Sweden). 26 Data were expressed in parts per billion (ppb).
| Statistical Analysis
| Exploratory analysis to identify trajectories of exacerbations
For ascertaining exacerbation patterns, we used primary care records data from birth to age 8 years, as this provided an objective account of hospital admissions, receipt of systemic corticosteroids and presence of wheeze. We used cluster analysis for longitudinal data to identify whether there are subgroups of patients with similar patterns of severe exacerbations. We applied a longitudinal extension of the k-means algorithm (KmL, a partitional clustering method), 27 and ascertained the optimal number of clusters using the Calinski-Harabatz criterion. 27 Results for post hoc longitudinal cluster analysis were obtained through the KmL package developed in R software. 28, 29 Technical details are provided in the online supplement.
| Characteristics of different trajectories of severe exacerbation
To assess differences between clusters (trajectories), we used either a t test, χ 2 test, Mann-Whitney test or one-way ANOVA as appropriate. To check which early-life risk factors predict trajectory membership, we used logistic regression models.
In order to identify differences between children with different exacerbation trajectories, those with wheezing but no exacerbations, and children who have never wheezed, we used multinomial logistic regression models with lung function, AHR, allergic sensitization, asthma severity and asthma medication as outcomes. All analysis was performed using R software (www.r-proje ct.org/). 30 
| RE SULTS
| Population characteristics and participant flow
Of 1184 children born into the cohort, 984 families gave consent for the review of medical records, of whom we extracted data for 887 children. Of those, 498 (56%) had physician-confirmed wheeze in their medical records on at least one occasion up to age 8 years, and 389 never wheezed. Of 498 children with wheezing, 338 had no exacerbations, and 160 (32%) had at least one confirmed severe exacerbation in the first 8 years; total number of exacerbations among these 160 children was 271. The number of children with at least one severe exacerbation in each year of life from birth to age 8 years is shown in Table E1 : the annual incidence was much higher in the first 4 years of life (5%), and then steadily reduced between ages 4 and 8 years to <2%. The median age of the first confirmed wheeze episode was 676 days (IQR: 187-863), and of the first severe exacerbation 893 days (IQR: 343-1238).
Descriptive characteristics of 160 children who had at least one severe exacerbation of wheezing are shown in Table E1 ; 68 (43%) had a physician diagnosis of asthma in the same period, and 116 (73%) were prescribed ICS at some point. Current use of ICS among current exacerbators in each 12-month period from birth to age 8 increased from 31% in the first year of life to 79% in year 8. Among children with exacerbation(s), on average 11% per annum had ≥ 3 exacerbations in the preceding 12 months; all but one of these children received asthma medication.
| Identification of trajectories of severe exacerbations and their associates
To identify exacerbation trajectories, we analysed data from 160 children who had at least one confirmed severe exacerbation from birth to age 8 years. According to the Calinski-Harabatz index ( Figure E1 ), the optimal model that best described the data was a 2-class solution. Figure 1 shows the exacerbation patterns in the two clusters (trajectories), and individual pattern of exacerbations within each trajectory. We assigned trajectories as "Infrequent exacerbations (IE)" (n = 150 [93.7%], median number of exacerbations = 1) and "Early-onset frequent exacerbations (FE)" (n = 10 [6.3%], median exacerbations number = 4).
| Early-life characteristics and clinical features
The associations of exacerbation trajectories with risk factors and clinical features in the first 8 years of life are presented in Table 1 . Shorter duration of breastfeeding was a strong risk factor for FE (median weeks, FE 0 [IQR: 0-1.75] vs. IE 6 (IQR: 0-20), P < .001). Family history of asthma and tobacco smoke exposure did not differ between clusters.
Children in FE cluster were significantly more likely to have eczema in the first 3 years of life, but not thereafter. Allergic sensitization and co-morbid rhinitis did not significantly differ between the clusters. By age 8 years, significantly higher proportion of children in the FE cluster had doctor-diagnosed asthma (90% vs. 39%, P = .002). The use of ICS was higher among children in FE cluster, particularly at age 3 years (80% vs. 22%, FE vs. IE, P < .001), and children in this cluster were more likely to have persistent wheeze (90% vs. 47%, P = .03).
The distribution of asthma severity in two exacerbation clusters is shown in Table E2 . Although most children in both clusters had mild asthma, those in FE cluster accounted for the higher percentage of more severe asthma, with significant difference between clusters at age 3 years (P = .03). Table 2 shows lung function, airway inflammation and AHR among children in the two exacerbation clusters. sR aw was markedly and significantly higher in FE compared with IE throughout childhood ( Figure   E2 cluster, but this did not reach statistical significance (P = .08). Table E3 shows Lung function data and FeNO in the four groups are shown in Table E4 . Lung function was significantly diminished in all 3 groups of children who have wheezed, with significantly lower levels in the FE cluster. FeNO was significantly increased in both exacerbation clusters (but not in the WNE group) and was significantly higher at age 8 years among those with FE compared to all other groups.
| Comparison with children who never wheezed, and wheezers with no severe exacerbations
| Asthma-related outcomes in adolescence
Asthma-related outcomes at age 16 years are shown in Table 3 .
Children in FE cluster were significantly more likely to have current asthma in adolescence than those who wheezed, but did not Lung function and FeNO at age 16 years are shown in Figure 2 and NW, WNE, IE, FE, respectively, P < .001). FeNO levels were significantly higher in all three groups of children who have wheezed compared to NW, with the highest levels among those in the FE cluster. 
| D ISCUSS I ON
| Key findings
To the best of our knowledge, this is the first study that has mapped longitudinal trajectories of severe of exacerbations of wheeze/ asthma during childhood using data-driven methodologies. We 
| Limitations and strengths
One limitation of our study is that we do not have a replication popu- population, which is similar to other UK cohorts. Non-UK cohorts showed either lower 3, 30 or higher 31 exacerbation rates, although some of the studies reporting higher exacerbation rates were carried out in high-risk populations with preponderance of severe asthmatics. 31 We acknowledge that there may be an underestimation of severe exacerbations among pre-school children as a consequence of a relatively stringent definition we used, and we cannot exclude the possibility that the underestimation of severity may be more likely requiring the use of oral and/or injectable corticosteroids-that is the phenotype which we focussed on relates to genuinely severe exacerbations. Importantly, our definition is based on objective data derived from healthcare records, which contain precise information on physician-confirmed episodes of wheeze, systemic corticosteroid prescriptions, emergency department admissions, and/or wheeze or asthma-related hospitalizations. Age in days at the time of each event was recorded, and we did not have to rely on the recollection of parents, which has been shown to be relatively inaccurate. 32 Another strength is that we used data-driven approach which has removed any a priori assumptions.
| Interpretation
This study builds upon our previously published work in a welldefined cohort of patients with asthma diagnosis. 3 Using similar methodology, we identified an exacerbation-prone asthma subtype, independent of asthma severity or control, which is consistent with current findings in the different setting of a population-based birth cohort.
Duration of breastfeeding was the most significant early-life risk factor for the early-onset frequent exacerbations trajectory, and children with the shortest duration of breastfeeding were more likely to experience exacerbations in early childhood. Our findings are consistent with results of the recent study by Ahmadizar et al, which has shown that breastfeeding is associated with a decreased risk of asthma exacerbations in later childhood. 33 These results are consistent with findings that breastfeeding may have immunomodulatory and anti-infective antimicrobial effects, 34 thereby impacting upon the risk of exacerbations (which are likely mostly virus-induced). 35 Breast milk contains high levels of immunoglobulins, lactoferrin, cytokines and prebiotic structures that influence the development of immune system. 36 Furthermore, it has been shown that breast milk can alter the composition of gut microbiome. 37 However, further experimental studies are required to clarify underlying mechanisms.
Children in the early-onset frequent exacerbations trajectory were more likely to have co-morbid eczema in early life (but not later in childhood). This is consistent with our recent finding that across different developmental profiles of wheeze, eczema and rhinitis, filaggrin locus (a major genetic risk factor for early-onset eczema) is differentially associated with eczema with co-morbid wheeze and rhinitis. 38 This trajectory appeared to be associated with early-onset allergic sensitization. This is in concordance with an exacerbation cluster identified by the Trousseau Asthma Programme, which could suggest that similar risk factors may be contributing to early-life sensitization and wheeze exacerbations. 39 We have observed a relatively high frequency of rhinitis in early school age among all children with physician-confirmed wheezing, with the proportion of subjects with rhinitis steadily increasing from those with no exacerbations (30%), to those in infrequent (37%) and frequent exacerbations trajectories (50%), compared to only 17% among children who have never wheezed. This extends recent findings that childhood rhinitis confers significant risk for asthma development 40 and suggests that both allergic non-allergic mechanisms are important for susceptibility to frequent exacerbations. 41 The proportion of children with more severe asthma in our cohort was highest among children who had frequent exacerbations.
However, a subset of children who experienced exacerbations had mild asthma with good symptom control, relatively low medication use and normal lung function. The could be explained in two ways: either these children were not on adequate therapy (eg only 50% of children in with FE trajectory were using ICS at age 8) and
were therefore having exacerbations, or, that these children were on correct symptomatic therapy, but continued to exacerbate due to some other underlying mechanism which is not influenced by ICS treatment. Our data provide indirect evidence that exacerbation-prone asthma may represent a separate asthma subtype, not necessarily associated with disease severity or control, or airway obstruction. Other recent studies using similar approaches have supported this notion. 3, 7 These findings emphasize the need for further research into mechanisms underlying susceptibility to severe exacerbations. 42 We found that frequent exacerbations trajectory was associated with more airway inflammation, airway hyperresponsiveness and poorer lung function, which is in line with previous studies. 4, 7, 31 It is of note that FEV 1 /FVC ratio was considerably and significantly lower among children with frequent exacerbations, and that it declined during childhood. A recent multi-cohort study has shown that frequent wheeze exacerbations in early childhood are associated with persistently low lung function trajectory which persists from early school age to the physiological peak in early adulthood, 43 and increases the risk of the development of chronic obstructive pulmonary disease. 44 Therefore, developing strategies to reduce early-life severe exacerbations may contribute to the improvement in lifelong lung health.
In conclusion, we have identified two distinct patterns (trajectories) of severe exacerbations of wheezing during childhood with different early-life risk factors and asthma-related outcomes in adolescence. Our results provide a proof-of-concept that there are different exacerbation trajectories, and that these trajectories are likely associated with different mechanisms. However, the proportion of subjects with early-onset frequent exacerbations is inevitably low (even in large birth cohort studies), rendering investigations into mechanisms difficult. Pooling the data from multiple birth cohorts, such as in STELAR 45 and CREW 46 
